Company intelligence / Profile preview

CELLINK

Gothenburg, Sweden

Ownership: Private
Employees: ~200
Development stage: Other

Overview

CELLINK is a global pioneer and leading brand in 3D bioprinting, supplying printers, bioinks, and consumables. Its products enable the creation of human tissue and organ models for life science research, drug discovery, and regenerative medicine. Cited in over 1000 publications and used by more than 1,600 laboratories across 65+ countries, CELLINK's platform enables more accurate preclinical models, reduces animal use in research, and is central to rapid innovation in cell-based tissue engineering. CELLINK does not develop its own therapeutics but provides the essential tools and platforms for others to do so.

Therapeutic areas: OncologyDermatologyOther
Modalities: DeviceBiomaterial
Industry: Non-Drug Biotech

Partnerships

AstraZenecaMedImmuneMITTakara BioCtibiotech

Beyond the preview

Go deeper on CELLINK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CELLINK.

Explore the full profile